Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Cereplast Inc (OTCMKTS:CERP), Plug Power Inc (NASDAQ:PLUG), BG Medicine, Inc. (NASDAQ:BGMD), Neurometrix Inc (NASDAQ:NURO)
Cereplast Inc (OTCMKTS:CERP) managed to keep its fall at -25% on above-normal volume of 38.87M shares. The stock settled at $0.0054 after floating in a range of $0.01 to $0.01. Its latest price has reached market capitalization of $3.89 million. Its 52-week range has been $0.01 to $0.07. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
Has CERP Found The Bottom and Ready To Move Up? Find Out Here
Plug Power Inc (NASDAQ:PLUG) traded up on a volume of 23 million, higher than its standard daily volume. Shares have gained 11.31% to $1.87. Over the last twelve months, the stock has gained 187.78% and faced a worst price of $0.12. Plug Power Inc. (Plug Power), is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road (forklift or material handling) market. The Company is focused on proton exchange membrane( PEM), fuel cell and fuel processing technologies and fuel cell/battery hybrid technologies, from which multiple products are available.
For How Long PLUG’s Gloss will Attract Investors? Find out via this report
BG Medicine, Inc. (NASDAQ:BGMD) settled 86.21% higher at $1.08 on above-normal volume of 21.39M shares during the last trading day. The stock has its 12-month high at $4.48 and 52-week low price was $0.55. It traded in a range of $0.61 to $1.29 during the last trading day. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a suppl.
Why Should Investors Buy BGMD After the Recent Fall? Just Go Here and Find Out
In the last trading session, Neurometrix Inc (NASDAQ:NURO) was up on high volume, trading at a volume of 8.52M versus its average daily volume of 1.10 million shares. At $3.10, the stock has attained market capitalization of 9.26 million. NeuroMetrix, Inc. (NeuroMetrix) is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company is in the position to address these unmet needs through the development of medical devices.
Will NURO Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)